source
- Eli Lilly reports strongest weight-loss data yet; Sanofi and Regeneron secure $1 billion upfront dealThe weekly Endpoints newsletter dated October 3, 2026 highlights that Eli Lilly's latest weight‑loss trial produced its best‑ever results. While the article does not provide specific numbers, the…
- Novartis pays $575 million upfront for access to Chinese biotech Abogen’s RNA platform and option on ABO-2203Novartis announced a deal with China‑based Abogen Biosciences that could be worth up to $7.8 billion. The agreement includes an upfront payment of $575 million. Under the deal, Abogen will provide…